ClinicalTrials.Veeva

Menu
C

Centro de Investigacion Clinica del Sur | Temuco, Chile

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tocilizumab
Apixaban
Milvexian
Talazoparib
Enzalutamide
GLPG0634
PF-06821497
Mevrometostat

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 7 total trials

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian
Locations recently updated

This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alon...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: PF-06821497
Drug: Placebo

This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of tal...

Active, not recruiting
mCRPC
Drug: Talazoparib with enzalutamide
Drug: Placebo with enzalutamide

Trial sponsors

Pfizer logo
Janssen (J&J Innovative Medicine) logo
G
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems